ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 121 filers reported holding ANI PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 3.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $358,695 | -79.2% | 6,178 | -80.7% | 0.00% | -100.0% |
| Q2 2023 | $1,726,490 | +271.6% | 32,073 | +174.2% | 0.00% | – |
| Q1 2023 | $464,605 | +69.4% | 11,697 | +71.6% | 0.00% | – |
| Q4 2022 | $274,248 | +27324.8% | 6,817 | +15393.2% | 0.00% | – |
| Q3 2022 | $1,000 | -92.9% | 44 | -90.9% | 0.00% | – |
| Q1 2022 | $14,000 | -94.9% | 481 | -91.8% | 0.00% | – |
| Q4 2021 | $273,000 | +415.1% | 5,901 | +262.7% | 0.00% | – |
| Q3 2021 | $53,000 | -36.1% | 1,627 | -31.1% | 0.00% | – |
| Q2 2021 | $83,000 | -42.4% | 2,360 | -40.4% | 0.00% | – |
| Q1 2021 | $144,000 | -0.7% | 3,963 | -20.6% | 0.00% | – |
| Q4 2020 | $145,000 | -35.8% | 4,993 | -37.4% | 0.00% | – |
| Q3 2020 | $226,000 | -61.1% | 7,981 | -55.6% | 0.00% | – |
| Q2 2020 | $581,000 | +86.8% | 17,990 | +136.2% | 0.00% | – |
| Q1 2020 | $311,000 | -66.8% | 7,617 | -49.9% | 0.00% | – |
| Q4 2019 | $937,000 | +32.7% | 15,195 | +57.1% | 0.00% | – |
| Q3 2019 | $706,000 | +100.0% | 9,674 | +125.5% | 0.00% | – |
| Q2 2019 | $353,000 | +4312.5% | 4,290 | +3475.0% | 0.00% | – |
| Q1 2019 | $8,000 | -20.0% | 120 | -45.0% | 0.00% | – |
| Q4 2018 | $10,000 | -89.9% | 218 | -87.6% | 0.00% | – |
| Q3 2018 | $99,000 | +120.0% | 1,754 | +162.2% | 0.00% | – |
| Q2 2018 | $45,000 | -48.9% | 669 | -55.5% | 0.00% | – |
| Q1 2018 | $88,000 | +363.2% | 1,504 | +408.1% | 0.00% | – |
| Q4 2017 | $19,000 | -87.1% | 296 | -89.4% | 0.00% | – |
| Q3 2017 | $147,000 | +40.0% | 2,792 | +25.0% | 0.00% | – |
| Q2 2017 | $105,000 | -53.9% | 2,234 | -51.6% | 0.00% | – |
| Q1 2017 | $228,000 | -45.5% | 4,612 | -33.1% | 0.00% | – |
| Q4 2016 | $418,000 | -67.3% | 6,899 | -64.2% | 0.00% | -100.0% |
| Q3 2016 | $1,280,000 | +57.6% | 19,287 | +32.7% | 0.00% | 0.0% |
| Q2 2016 | $812,000 | +1149.2% | 14,539 | +654.9% | 0.00% | – |
| Q1 2016 | $65,000 | -26.1% | 1,926 | -1.5% | 0.00% | – |
| Q4 2015 | $88,000 | +4300.0% | 1,955 | +3213.6% | 0.00% | – |
| Q3 2015 | $2,000 | -99.6% | 59 | -99.3% | 0.00% | – |
| Q2 2015 | $537,000 | +215.9% | 8,649 | +218.1% | 0.00% | – |
| Q1 2015 | $170,000 | +304.8% | 2,719 | +262.5% | 0.00% | – |
| Q4 2014 | $42,000 | – | 750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 272,801 | $15,838,826 | 7.50% |
| Global Alpha Capital Management Ltd. | 525,528 | $30,512,156 | 3.06% |
| Rubric Capital Management LP | 847,011 | $49,177,459 | 1.84% |
| Ranger Investment Management | 426,848 | $24,782,795 | 1.64% |
| Parkman Healthcare Partners LLC | 111,802 | $6,491,224 | 1.19% |
| MARATHON CAPITAL MANAGEMENT | 71,670 | $4,161,160 | 1.05% |
| Mesirow Financial Investment Management, Inc. | 3,862 | $224,228 | 0.98% |
| Deep Track Capital, LP | 400,000 | $23,224,000 | 0.90% |
| 1492 Capital Management LLC | 18,178 | $1,055,415 | 0.68% |
| Phocas Financial Corp. | 75,213 | $4,367,000 | 0.64% |